Please see below to view details for this session presenter

Jon Northrup

Chief Executive Officer, Beta Cat Pharmaceuticals

Mr. Northrup has served as CEO of Beta Cat Pharmaceuticals, an emerging cancer biotech with highly novel small molecule drugs, effective on cancer stem cell and epigenetic targets, since 2010. Prior to Beta Cat, Mr. Northrup was COO of Jubilant Innovation, the VC arm of Jubilant Life Sciences, a major Indian pharmaceutical services provider, for 5 years.  Mr. Northrup has had a successful consultancy representing pharma service companies in India, China and Korea.  Mr. Northrup was a senior executive at Eli Lilly across positions in strategy, corporate business development, product marketing, sales management and finance, where he left at the VP level. He has an MBA from the Wharton School and is a Certified Licensing Professional (CLP).